Amalgamated Bank Decreases Stake in CVS Health Co. (NYSE:CVS)

Amalgamated Bank lowered its stake in CVS Health Co. (NYSE:CVS - Free Report) by 3.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 241,458 shares of the pharmacy operator's stock after selling 7,829 shares during the quarter. Amalgamated Bank's holdings in CVS Health were worth $10,839,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. MidAtlantic Capital Management Inc. purchased a new stake in shares of CVS Health in the 3rd quarter valued at about $25,000. Legacy Investment Solutions LLC purchased a new stake in shares of CVS Health in the 3rd quarter valued at about $31,000. Reston Wealth Management LLC purchased a new stake in shares of CVS Health in the 3rd quarter valued at about $32,000. Ridgewood Investments LLC raised its holdings in shares of CVS Health by 255.7% in the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock valued at $28,000 after acquiring an additional 450 shares in the last quarter. Finally, Stonebridge Financial Group LLC purchased a new position in shares of CVS Health during the 4th quarter valued at about $28,000. Hedge funds and other institutional investors own 80.66% of the company's stock.

Analyst Upgrades and Downgrades

CVS has been the topic of a number of research reports. Argus set a $77.00 price objective on CVS Health in a report on Tuesday, February 18th. UBS Group decreased their price objective on CVS Health from $62.00 to $59.00 and set a "neutral" rating on the stock in a report on Tuesday, February 11th. Leerink Partners raised CVS Health from a "market perform" rating to an "outperform" rating and raised their price objective for the company from $55.00 to $75.00 in a report on Thursday, February 13th. JPMorgan Chase & Co. raised their price objective on CVS Health from $80.00 to $81.00 and gave the company an "overweight" rating in a report on Tuesday, February 18th. Finally, Piper Sandler reduced their price target on CVS Health from $72.00 to $64.00 and set an "overweight" rating on the stock in a research report on Monday, November 25th. Four equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $69.83.

CVS Health Stock Up 2.1 %

Shares of NYSE CVS traded up $1.37 during mid-day trading on Friday, hitting $65.85. 10,474,843 shares of the stock traded hands, compared to its average volume of 12,550,715. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $80.75. The company has a market cap of $83.02 billion, a price-to-earnings ratio of 17.99, a PEG ratio of 0.98 and a beta of 0.61. The stock has a fifty day moving average price of $54.33 and a 200-day moving average price of $56.46.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. Research analysts anticipate that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.04%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health's payout ratio is 72.68%.

Insider Buying and Selling at CVS Health

In related news, Director Michael F. Mahoney acquired 30,000 shares of the stock in a transaction on Tuesday, February 18th. The stock was acquired at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the purchase, the director now owns 39,356 shares of the company's stock, valued at $2,625,045.20. This represents a 320.65 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.24% of the stock is owned by company insiders.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.